Oesterling JE - Search Results

1

Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study.

DeAntoni EP, Crawford ED, Oesterling JE, Ross CA, Berger ER, McLeod DG, Staggers F, Stone NN. DeAntoni EP, et al. Among authors: oesterling je. Urology. 1996 Aug;48(2):234-9. doi: 10.1016/s0090-4295(96)00091-x. Urology. 1996. PMID: 8753735

2

The clinical usefulness of prostate specific antigen: update 1994.

Partin AW, Oesterling JE. Partin AW, et al. Among authors: oesterling je. J Urol. 1994 Nov;152(5 Pt 1):1358-68. doi: 10.1016/s0022-5347(17)32422-9. J Urol. 1994. PMID: 7523702 Free article. Review.

3

The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older.

Oesterling JE, Jacobsen SJ, Cooner WH. Oesterling JE, et al. J Urol. 1995 Apr;153(4):1160-3. J Urol. 1995. PMID: 7532725

4

Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysis.

Partin AW, Criley SR, Subong EN, Zincke H, Walsh PC, Oesterling JE. Partin AW, et al. Among authors: oesterling je. J Urol. 1996 Apr;155(4):1336-9. J Urol. 1996. PMID: 8632568

5

Prostate specific antigen in hormonally treated stage D2 prostate cancer: is it always an accurate indicator of disease status?

Leo ME, Bilhartz DL, Bergstralh EJ, Oesterling JE. Leo ME, et al. Among authors: oesterling je. J Urol. 1991 Apr;145(4):802-6. doi: 10.1016/s0022-5347(17)38456-2. J Urol. 1991. PMID: 1706440

6

Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasia.

Monda JM, Barry MJ, Oesterling JE. Monda JM, et al. Among authors: oesterling je. J Urol. 1994 May;151(5):1291-5. doi: 10.1016/s0022-5347(17)35234-5. J Urol. 1994. PMID: 7512660

7

Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men.

Oesterling JE, Kumamoto Y, Tsukamoto T, Girman CJ, Guess HA, Masumori N, Jacobsen SJ, Lieber MM. Oesterling JE, et al. Br J Urol. 1995 Mar;75(3):347-53. doi: 10.1111/j.1464-410x.1995.tb07347.x. Br J Urol. 1995. PMID: 7537604 Free article.

8

The correlation between serum prostate-specific antigen and prostate cancer is not influenced by the serum testosterone concentration.

Monda JM, Myers RP, Bostwick DG, Oesterling JE. Monda JM, et al. Among authors: oesterling je. Urology. 1995 Jul;46(1):62-4. doi: 10.1016/S0090-4295(99)80160-5. Urology. 1995. PMID: 7541588

9

Clinical Stage B0 or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate-specific antigen concentration.

Stormont TJ, Farrow GM, Myers RP, Blute ML, Zincke H, Wilson TM, Oesterling JE. Stormont TJ, et al. Among authors: oesterling je. Urology. 1993 Jan;41(1):3-8. doi: 10.1016/0090-4295(93)90233-z. Urology. 1993. PMID: 7678359

10

Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration.

Oesterling JE, Rice DC, Glenski WJ, Bergstralh EJ. Oesterling JE, et al. Urology. 1993 Sep;42(3):276-82. doi: 10.1016/0090-4295(93)90616-i. Urology. 1993. PMID: 7691013 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters